Annual ROE
45.99%
-26.18%-36.28%
31 December 2023
Summary:
Esperion Therapeutics annual return on equity is currently 45.99%, with the most recent change of -26.18% (-36.28%) on 31 December 2023. During the last 3 years, it has fallen by -103.33% (-69.20%). ESPR annual ROE is now -69.20% below its all-time high of 149.32%, reached on 31 December 2020.ESPR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
23.71%
-2.49%-9.50%
30 September 2024
Summary:
Esperion Therapeutics quarterly return on equity is currently 23.71%, with the most recent change of -2.49% (-9.50%) on 30 September 2024. Over the past year, it has dropped by -34.36% (-59.17%). ESPR quarterly ROE is now -97.86% below its all-time high of 1105.71%, reached on 31 December 2020.ESPR Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.3% | -59.2% |
| 3 y3 years | -69.2% | -80.2% |
| 5 y5 years | +136.9% | +128.1% |
ESPR ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -69.2% | at low | -80.2% | +4.9% |
| 5 y | 5 years | -69.2% | +123.5% | -97.9% | +106.2% |
| alltime | all time | -69.2% | +112.1% | -97.9% | +102.1% |
Esperion Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 23.71%(-9.5%) |
| June 2024 | - | 26.20%(+15.9%) |
| Mar 2024 | - | 22.60%(-57.7%) |
| Dec 2023 | 45.99%(-36.3%) | 53.43%(-8.0%) |
| Sept 2023 | - | 58.07%(-13.8%) |
| June 2023 | - | 67.38%(-12.5%) |
| Mar 2023 | - | 77.03%(-4.5%) |
| Dec 2022 | 72.17%(-47.2%) | 80.67%(-14.5%) |
| Sept 2022 | - | 94.32%(+0.7%) |
| June 2022 | - | 93.63%(+10.9%) |
| Mar 2022 | - | 84.42%(-11.1%) |
| Dec 2021 | 136.64%(-8.5%) | 94.98%(-20.5%) |
| Sept 2021 | - | 119.50%(-39.2%) |
| June 2021 | - | 196.42%(-14.8%) |
| Mar 2021 | - | 230.54%(-79.2%) |
| Dec 2020 | 149.32%(-176.1%) | 1105.71%(-390.4%) |
| Sept 2020 | - | -380.74%(+129.5%) |
| June 2020 | - | -165.91%(-56.7%) |
| Mar 2020 | - | -383.57%(+272.6%) |
| Dec 2019 | -196.16%(+57.4%) | -102.95%(+22.1%) |
| Sept 2019 | - | -84.30%(+41.4%) |
| June 2019 | - | -59.62%(+22.6%) |
| Mar 2019 | - | -48.63%(-63.8%) |
| Dec 2018 | -124.65% | -134.33%(+43.3%) |
| Sept 2018 | - | -93.76%(+22.3%) |
| June 2018 | - | -76.67%(-1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | -77.47%(+0.8%) |
| Dec 2017 | -70.56%(+142.7%) | -76.84%(+3.7%) |
| Sept 2017 | - | -74.10%(+18.0%) |
| June 2017 | - | -62.82%(+46.7%) |
| Mar 2017 | - | -42.81%(+46.8%) |
| Dec 2016 | -29.07%(+22.9%) | -29.16%(+34.0%) |
| Sept 2016 | - | -21.76%(+12.6%) |
| June 2016 | - | -19.32%(+6.6%) |
| Mar 2016 | - | -18.13%(+9.6%) |
| Dec 2015 | -23.66%(-32.5%) | -16.54%(-5.9%) |
| Sept 2015 | - | -17.57%(-18.1%) |
| June 2015 | - | -21.46%(-25.2%) |
| Mar 2015 | - | -28.70%(-38.9%) |
| Dec 2014 | -35.04%(-61.9%) | -46.98%(-19.7%) |
| Sept 2014 | - | -58.51%(+29.3%) |
| June 2014 | - | -45.24%(-9.7%) |
| Mar 2014 | - | -50.11%(-8.8%) |
| Dec 2013 | -92.02%(-236.3%) | -54.93%(-29.5%) |
| Sept 2013 | - | -77.88%(-77.1%) |
| June 2013 | - | -340.21%(-70.4%) |
| Mar 2013 | - | -1149.66%(-1802.7%) |
| Dec 2012 | 67.52%(-202.0%) | 67.52% |
| Dec 2011 | -66.19%(+21.2%) | - |
| Dec 2002 | -54.59%(+46.9%) | - |
| Dec 2001 | -37.16%(-52.5%) | - |
| Dec 2000 | -78.22%(-79.4%) | - |
| Dec 1999 | -379.04% | - |
FAQ
- What is Esperion Therapeutics annual return on equity?
- What is the all time high annual ROE for Esperion Therapeutics?
- What is Esperion Therapeutics annual ROE year-on-year change?
- What is Esperion Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly ROE year-on-year change?
What is Esperion Therapeutics annual return on equity?
The current annual ROE of ESPR is 45.99%
What is the all time high annual ROE for Esperion Therapeutics?
Esperion Therapeutics all-time high annual return on equity is 149.32%
What is Esperion Therapeutics annual ROE year-on-year change?
Over the past year, ESPR annual return on equity has changed by -26.18% (-36.28%)
What is Esperion Therapeutics quarterly return on equity?
The current quarterly ROE of ESPR is 23.71%
What is the all time high quarterly ROE for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly return on equity is 1105.71%
What is Esperion Therapeutics quarterly ROE year-on-year change?
Over the past year, ESPR quarterly return on equity has changed by -34.36% (-59.17%)